Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Frontal fibrosing alopecia significantly affects men, often causing hair loss in eyebrows, beard, and sideburns.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Stopping shaving or removing hair follicles usually resolves Pseudofolliculitis barbae.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

FFA can be mistaken for rosacea, requiring specific treatment for accurate diagnosis and management.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

High-frequency ultrasound effectively evaluates and diagnoses frontal fibrosing alopecia.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Computer-aided imaging system helps measure balding area in female pattern hair loss.

The document concludes that stopping shaving or removing affected hair can alleviate Pseudofolliculitis barbae (PFB).

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

HFMs can help study hair growth and test potential hair growth drugs.

EFBL offers hidden incisions, faster recovery, and fewer risks, but may raise hairline and cost more.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.